GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we treat type 2 diabetes . These new drugs help stimulating the body’s own GLP-1 hormone , which https://olivebookmarks.com/story21820017/glp-1-a-significant-breakthrough-in-glucose-treatment